IL6 and sleep disorder: Since the hyperactivity of kynurenine pathway sleep disorders is secondary, at least in part, to increased levels of cortisol and proinflammatory cytokines [37], we analyzed if the affron®-induced decreased activation of this pathway was related to modifications in the circulating levels of interleukin-6 (IL-6) and corticosterone.